Related references
Note: Only part of the references are listed.Current and emerging drug treatment strategies for polycystic ovary syndrome
Nafiye Helvaci et al.
EXPERT OPINION ON PHARMACOTHERAPY (2023)
Exposure-Response Relationship of Tranexamic Acid in Cardiac Surgery A Model-based Meta-analysis
Paul Jacques Zufferey et al.
ANESTHESIOLOGY (2021)
Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses
Helena Teede et al.
CLINICAL ENDOCRINOLOGY (2019)
Model-Based Meta-Analysis: Optimizing Research, Development, and Utilization of Therapeutics Using the Totality of Evidence
Vijay V. Upreti et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Combined oral contraceptives and/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis
Manuel Luque-Ramirez et al.
HUMAN REPRODUCTION UPDATE (2018)
Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis
Mina Amiri et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2018)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede et al.
HUMAN REPRODUCTION (2018)
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
Hector F. Escobar-Morreale
NATURE REVIEWS ENDOCRINOLOGY (2018)
Many Flavors of Model-Based Meta-Analysis: Part II - Modeling Summary Level Longitudinal Responses
Martin Boucher et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta analysis comparing products containing cyproterone acetate with third generation progestins
Mina Amiri et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome
Sebastiao Freitas de Medeiros
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2017)
Noncontraceptive use of oral combined hormonal contraceptives in polycystic ovary syndrome-risks versus benefits
Anuja Dokras
FERTILITY AND STERILITY (2016)
Hormonal contraceptives: pharmacology tailored to women's health
Vincenzo De Leo et al.
HUMAN REPRODUCTION UPDATE (2016)
Model-Based Network Meta-Analysis: A Framework for Evidence Synthesis of Clinical Trial Data
D. Mawdsley et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis
Negar Naderpoor et al.
HUMAN REPRODUCTION UPDATE (2015)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Gerard Conway et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics
Hoai-Thu Thai et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills
Regine Sitruk-Ware et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance
W. Byon et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
Bart C. J. M. Fauser et al.
FERTILITY AND STERILITY (2012)
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society
H. F. Escobar-Morreale et al.
HUMAN REPRODUCTION UPDATE (2012)
Model-Based Meta-Analysis for Comparative Efficacy and Safety: Application in Drug Development and Beyond
J. W. Mandema et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Long-term consequences of polycystic ovary syndrome on cardiovascular risk
Manfredi Rizzo et al.
FERTILITY AND STERILITY (2009)
Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline
Ricardo Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Combined oral contraceptives in the treatment of polycystic ovary syndrome
J Vrbíková et al.
HUMAN REPRODUCTION UPDATE (2005)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
The prevalence and features of the polycystic ovary syndrome in an unselected population
R Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Current concepts in the polycystic ovary syndrome
A Dunaif et al.
ANNUAL REVIEW OF MEDICINE (2001)
Share Paper
